High Mortality Risk in Patients With Leukemia Hospitalized With CDI
Among patients with leukemia admitted to the hospital with Clostridioides difficile infection...
Read More
Meeting Coverage
ASCO: A Focus on Lung Cancer
ASCO Lung Cancer Annual 2022.indd
Read More
Various Racial Disparities in Patients With TP53m Acute Myeloid Leukemia
Black/Hispanic patients with TP53 mutation (m) acute myeloid leukemia (AML) had worse overall...
Read MoreVarious Racial Disparities in Patients With TP53m Acute Myeloid Leukemia
Black/Hispanic patients with TP53 mutation (m) acute myeloid leukemia (AML) had worse overall survival (OS) compared with White patients, according to study results presented by Talha Badar, MBBS, MD, at the 2022 American...
Read More
Once-Daily Radiotherapy Preferred by Patients With Limited Stage Small Cell Lung Cancer
High-dose, once-daily thoracic radiotherapy (TRT) and standard twice daily TRT were well tolerated...
Read More
Most Patients With Multiple Sclerosis Experience Spasticity Daily
Most patients with MS experience spasticity daily, with varying degrees of severity and duration,...
Read More
Multiple Sclerosis-Related Cognitive Impairment Perceptions Differ Between Patients & Physicians
Factors affecting self-reported cognitive impairment (CI) among patients with multiple sclerosis...
Read More
Quadruple Therapy Phase II Data for EGFR-mutated NSCLC
Atezolizumab plus bevacizumab plus carboplatin plus paclitaxel (ABCP) is a promising regimen for...
Read More
Determining Whether Adding RP1 to Cemiplimab Helps CSCC Patients
A presentation at the American Society of Clinical Oncology (ASCO) 2022 Annual meeting, which was...
Read More
Acalabrutinib Still Outperforming in R/R CLL: Three-years Follow-up of ASCEND
A presentation at the American Society of Clinical Oncology (ASCO) 2022 Annual meeting, which was...
Read More
OS benefit seen in 5-year data on ELEVATE-TN trial in CLL
A presentation at the American Society of Clinical Oncology (ASCO) 2022 Annual meeting, which was...
Read More
Add-on Tiragolumab Doesn’t Improve on Atezolizumab in Extensive Stage Small Cell Lung Cancer
A Late-breaking session at the American Society of Clinical Oncology (ASCO) 2022 Annual meeting,...
Read More
Randomized Trial for High-risk Cutaneous Squamous Cell Carcinoma Patients Treated With Adjuvant Cemiplimab
High-risk patients with cutaneous squamous cell carcinoma (CSCC) have an unmet need with regard to...
Read More
Most With MS Experience Early-Onset Fatigue
Most individuals with MS reported mild fatigue early in their disease course, at least one-half of...
Read More
Wellness Program Improves Disease Markers & Physical Activity in Patients With MS
Patients with MS who participated in a weekly, structured wellness program demonstrated ongoing,...
Read More
SKYSCRAPER-02: Additional Tiragolumab Does Not Help Patients With Untreated SCLC
Tiragolumab, added to atezolizumab, carboplatin, and etoposide, did not improve the...
Read MoreASCO Voices Event
This year ASCO Voices will be held on Saturday, June 4, from 12:00 PM – 1:00 PM CDT, at the Arie Crown Theater in McCormick Place Here are this year’s ASCO Voices: Cancer: Common Humanity, Different Worlds Kevin...
Read MoreASCO Voices Event
This year ASCO Voices will be held on Saturday, June 4, from 12:00 PM – 1:00 PM CDT, at the Arie Crown Theater in McCormick Place Here are this year’s ASCO Voices: Cancer: Common Humanity, Different Worlds Kevin...
Read MoreASCO Voices Event
This year ASCO Voices will be held on Saturday, June 4, from 12:00 PM – 1:00 PM CDT, at the Arie Crown Theater in McCormick Place Here are this year’s ASCO Voices: Cancer: Common Humanity, Different Worlds Kevin...
Read More